4//SEC Filing
SHERMAN JEFFREY W 4
Accession 0001867096-25-000110
CIK 0001867096other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 7:02 PM ET
Size
6.0 KB
Accession
0001867096-25-000110
Insider Transaction Report
Form 4
SHERMAN JEFFREY W
Director
Transactions
- Award
Common Stock
2025-06-04+50,000→ 214,380 total
Holdings
- 5,400(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001230482
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 7:02 PM ET
- Size
- 6.0 KB